AU4295500A - Oral form of administration - Google Patents

Oral form of administration

Info

Publication number
AU4295500A
AU4295500A AU42955/00A AU4295500A AU4295500A AU 4295500 A AU4295500 A AU 4295500A AU 42955/00 A AU42955/00 A AU 42955/00A AU 4295500 A AU4295500 A AU 4295500A AU 4295500 A AU4295500 A AU 4295500A
Authority
AU
Australia
Prior art keywords
administration
oral form
capsule
foodstuffs
xylose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU42955/00A
Inventor
Friedel Frauendorfer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sintetica GmbH
Original Assignee
Meduna Arzneimittel GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meduna Arzneimittel GmbH filed Critical Meduna Arzneimittel GmbH
Publication of AU4295500A publication Critical patent/AU4295500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention relates to an oral form of administration for foodstuffs as well as for foodstuff supplements and dietary products which comprises several unsaturated fatty acids in a xylose-hardened gelatine capsule with a delayed capsule opening time.
AU42955/00A 1999-06-30 2000-04-13 Oral form of administration Abandoned AU4295500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19930030A DE19930030B4 (en) 1999-06-30 1999-06-30 Oral dosage form containing CO-3-unsaturated fatty acids
DE19930030 1999-06-30
PCT/EP2000/003350 WO2001001797A1 (en) 1999-06-30 2000-04-13 Oral form of administration

Publications (1)

Publication Number Publication Date
AU4295500A true AU4295500A (en) 2001-01-22

Family

ID=7913095

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42955/00A Abandoned AU4295500A (en) 1999-06-30 2000-04-13 Oral form of administration

Country Status (9)

Country Link
EP (1) EP1091659B1 (en)
AT (1) ATE217494T1 (en)
AU (1) AU4295500A (en)
CA (1) CA2335713C (en)
CZ (1) CZ295721B6 (en)
DE (2) DE19930030B4 (en)
HU (1) HU230881B1 (en)
PL (1) PL197477B1 (en)
WO (1) WO2001001797A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPS088702A0 (en) 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
GB0311081D0 (en) 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
EP1529524B1 (en) * 2003-11-06 2006-02-01 Meduna Arzneimittel GmbH Softgelatine capsule comprising fat-soluble vitamins and essential fatty acids
FR2865353B1 (en) * 2004-01-23 2009-01-09 Synergia Holding NEW DIETETIC OR FOOD COMPLEMENTS BASED ON UNSATURATED FATTY ACID AND THEIR USE
GB0504362D0 (en) 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
EP2081550B2 (en) 2006-03-09 2021-05-26 Reliant Pharmaceuticals, Inc. Coating capsules with active pharmaceutical ingredients
US8784886B2 (en) 2006-03-09 2014-07-22 GlaxoSmithKline, LLC Coating capsules with active pharmaceutical ingredients
WO2012079118A1 (en) 2010-12-13 2012-06-21 Borody Thomas J Gastric and colonic formulations and methods for making and using them
WO2013174884A1 (en) * 2012-05-23 2013-11-28 Capsugel France SAS Capsules having an incorporated taste modifying component
WO2014016671A2 (en) 2012-07-27 2014-01-30 Redhill Biopharma Ltd. Formulations and methods of manufacturing formulations for use in colonic evacuation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3676491D1 (en) * 1986-04-05 1991-02-07 Scherer Gmbh R P GELATINE CAPSULES WITH CONTROLLED ACTIVE SUBSTANCE RELEASE AND METHOD FOR THE PRODUCTION THEREOF.
GB2223943A (en) * 1988-10-21 1990-04-25 Tillotts Pharma Ag Oral disage forms of omega-3 polyunsaturated acids
US4936074A (en) * 1988-11-17 1990-06-26 D. M. Graham Laboratories, Inc. Process for preparing solid encapsulated medicament
EP0623018B1 (en) * 1992-01-17 1995-12-27 ALFATEC-PHARMA GmbH Process for the manufacture of soft gelatin capsules by a drip-feed method
GB9509764D0 (en) * 1995-05-15 1995-07-05 Tillotts Pharma Ag Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
JPH09201A (en) * 1995-06-23 1997-01-07 Akikuni Yakida Food for inflammatory intestine disease
JPH11510148A (en) * 1995-08-02 1999-09-07 ワーナー−ランバート・カンパニー Hard gelatin capsule with low water transport and method for producing the same
DE19611953A1 (en) * 1996-03-26 1997-10-02 Beiersdorf Ag Use of unsaturated monocarboxylic acids against superinfections

Also Published As

Publication number Publication date
HU230881B1 (en) 2018-11-29
CA2335713A1 (en) 2001-01-11
HUP0201667A3 (en) 2003-02-28
PL353212A1 (en) 2003-11-03
WO2001001797A1 (en) 2001-01-11
EP1091659A1 (en) 2001-04-18
HUP0201667A2 (en) 2002-09-28
ATE217494T1 (en) 2002-06-15
DE19930030B4 (en) 2004-02-19
CA2335713C (en) 2004-10-26
CZ20014720A3 (en) 2002-05-15
DE50000168D1 (en) 2002-06-20
EP1091659B1 (en) 2002-05-15
PL197477B1 (en) 2008-04-30
CZ295721B6 (en) 2005-10-12
DE19930030A1 (en) 2001-01-11

Similar Documents

Publication Publication Date Title
WO2001058271A8 (en) Nutritional supplements for aged pets
AU4139693A (en) Foodstuffs and feedstuffs containing a lipase inhibitor
DE60005152D1 (en) MEDICINAL PRODUCTS, FOOD ADDITIVES AND COSMETIC PREPARATION CONTAINING A FATTY ACID AND GINGER
AU3472193A (en) Encapsulated dietary fatty acid salt products
AU4295500A (en) Oral form of administration
PT1233969E (en) Mono- and disaccharide derivatives
MXPA04001129A (en) Lipid blends and food products containing oleic fatty acid and omega-6 fatty acids, designed to increase the intramyocellular lipid level.
HUP0000042A2 (en) Omega-3-fatacid and vitamin containing meet product
AU2001236616A1 (en) Improved stability conjugated linoleic acid composition for dietary supplement and food uses
GB2379855A (en) Dietary regime for companion animals
WO2001078531A3 (en) Conjugated linoleic acid powder
CA2285552A1 (en) Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate
WO2003049687A3 (en) Medicinal compositions & therapeutic methods
AU7863400A (en) Nutraceutical products containing same and dietary supplements and method of manufacture and use thereof
AU1453401A (en) Compositions and methods for calcium fortification of dairy products and oleaginous foods
AU2003303360A1 (en) Dietary foodstuff for positively influencing cardiovascular health containing a carob product and an omega-3 fatty acid
FI952764A0 (en) Inhibition of bacterial growth
PL371599A1 (en) Food product comprising a phytosterol
AU3371793A (en) Process for the production of preservative edible supplements for food etc
AU2001267791A1 (en) Nutritional food product and process for its preparation
AU2003238106A1 (en) Lignan complexes
AU4757296A (en) Methods and compositions to add flavor to food products containing lipid
WO1999037167A3 (en) Process of improving the stability of vitamin d in a nutritional product containing hydrolyzed protein and product produced thereby
ES2087027A1 (en) Thermogenic nutritional supplements, foods that contain them, and applications.
ATE288208T1 (en) DIETARY FOOD

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase